Alyeska Investment Group, L.P. Kala Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $5,953 - $8,332	-948 Reduced 0.79%	118,493 $803,000
Q3 2020 Nov 16, 2020	BUY	$7.5 - $11.11 $77,505 - $114,810	10,334 Added 9.47%	119,441 $895,000
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $1.17 Million - $1.94 Million	-140,338 Reduced 56.26%	109,107 $1.15 Million
Q1 2020 May 15, 2020	SELL	$3.83 - $8.79 $719,178 - $1.65 Million	-187,775 Reduced 42.95%	249,445 $2.19 Million
Q4 2019 Feb 14, 2020	BUY	$3.36 - $4.81 $125,274 - $179,336	37,284 Added 9.32%	437,220 $1.61 Million
Q3 2019 Nov 14, 2019	BUY	$3.57 - $6.58 $178,500 - $329,000	50,000 Added 14.29%	399,936 $1.52 Million
Q2 2019 Aug 14, 2019	BUY	$4.93 - $8.8 $948,837 - $1.69 Million	192,462 Added 122.22%	349,936 $0
Q1 2019 May 15, 2019	BUY	$5.19 - $8.97 $2,460 - $4,251	474 Added 0.3%	157,474 $0
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $30,231 - $70,047	7,047 Added 4.7%	157,000 $768,000
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.49 $63,773 - $83,864	4,795 Added 3.3%	149,953 $2.06 Million
Q1 2018 May 15, 2018	SELL	$12.26 - $18.98 $549,762 - $851,101	-44,842 Reduced 23.6%	145,158 $2.3 Million
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $858,091 - $1.45 Million	62,726 Added 49.28%	190,000 $3.51 Million
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $2.53 Million - $3.38 Million	127,274	127,274 $2.91 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.